Erlotinib vs Sumatriptan

Erlotinib vs Sumatriptan: Overview

This comparison examines the pharmacological differences between Erlotinib and Sumatriptan.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Sumatriptan: Selective 5-HT1B/1D receptor agonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Sumatriptan — 2.5 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Sumatriptan — C14H21N3O2S.

Molecular Weight: Erlotinib — 393.4380 g/mol; Sumatriptan — 295.4020 g/mol.

Type: Erlotinib — Small molecule; Sumatriptan — Small molecule.